SCHEMBL6944619

SCHEMBL6944619

CCCC(O)N1CCC(OC)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.30
KCNQ3 O43525 1/20 0.30
KCNQ2 O43526 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19617820 0.87 AOC3 (0.31) AOC3KCNQ3KCNQ2
SCHEMBL24172173 0.81
SCHEMBL25922271 0.81
SCHEMBL5986092 0.77 HRH3 (0.33) KCNQ3KCNQ2
SCHEMBL24167623 0.76 HRH3 (0.31)
SCHEMBL25921599 0.76 HRH3 (0.31)
SCHEMBL25933733 0.76 HRH3 (0.31)
SCHEMBL23797076 0.76 FFAR4 (0.40)
SCHEMBL23809849 0.74 DPP4 (0.30)
SCHEMBL21779876 0.74 HRH3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003103652-A1 METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed